piramal pharma

  1. Vidhi Khanna
    Thread

    Piramal Pharma's long term prospects are intact. Buy for target price of ₹290 (+38%)

    Piramal Pharma's long term prospects are intact. Though CDMO growth in FY26 is muted, management has reiterated its FY30 aspirational revenue...
    Thread by: Vidhi Khanna, May 15, 2025, 0 replies, in forum: Latest Brokerage Stock Buy-Sell Reports
  2. Vidhi Khanna
    Thread

    Piramal Pharma is seeing strong momentum in CDMO. Buy for TP ₹320 (27% upside)

    Piramal Pharma is seeing strong momentum in CDMO. Postponement of the Biosecure Act is unlikely to cause growth related issues as China...
    Thread by: Vidhi Khanna, Dec 25, 2024, 0 replies, in forum: Latest Brokerage Stock Buy-Sell Reports
  3. Vidhi Khanna
    Thread

    Piramal Pharma is a conviction pick for Target Price of ₹210 (42% upside)

    Piramal Pharma is a conviction pick. Co is at critical inflection point. Overall improvement is expected as CDMO momentum continues. Complex...
    Thread by: Vidhi Khanna, Jul 23, 2024, 0 replies, in forum: Latest Brokerage Stock Buy-Sell Reports
  4. Vidhi Khanna
    Thread

    Buy Piramal Pharma for TP of 200 (42% gain)

    Buy Piramal Pharma for TP of 200 (42% gain). Growing req for development services (complex regulatory processes for new drugs), high entry...
    Thread by: Vidhi Khanna, Nov 15, 2022, 0 replies, in forum: Latest Brokerage Stock Buy-Sell Reports
Showing results 1 to 4 of 4